SHORT REPORT |
|
Year : 2009 | Volume
: 8
| Issue : 1 | Page : 52-54 |
|
Chronic kidney disease screening and renoprotection in type 2 diabetes
EI Agaba1, FH Puepet2, SO Ugoya2, PA Agaba3, R Adabe1, M Duguru1, AI Rowland2
1 Renal Unit, Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria 2 Endocrinology Unit, Department of Medicine, Jos University Teaching Hospital, Jos, Nigeria 3 AIDS Preventive Initiative, Nigeria Center, Jos University Teaching Hospital, Jos, Nigeria
Correspondence Address:
E I Agaba Department of Medicine, Jos University Teaching Hospital, P.M.B. 2076, Jos Nigeria
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1596-3519.55765
|
|
Background : Type 2 diabetes (T2D) is a major cause of chronic kidney disease. Control of hypertension and the use of angiotensin converting enzyme inhibitors (ACEI) and/or angiotensin II receptor blockers especially in those with proteinuria have been shown to protect against chronic kidney disease and delay its progression to kidney failure.
Methods : We reviewed the medical records of 169 patients at 12 months with a view of auditing the screening for chronic kidney disease and the use of renoprotective measures.
Results : Urinalysis was done in 49.1% and serum creatinine in 50.3%. No patient had glomerular filtration rate estimated. Seventy nine (67.6%) of the hypertensive patients were on anti-hypertensives. ACEI was used in 49 (45.8%) of these patients BP control was optimal in 29.1%.
Conclusion : There is poor adherence to guidelines on chronic kidney disease screening and renoprotection in T2D.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|